News

IT’S MOVING DAY!

We have been growing in the number of employees, new instruments and lately, we have acquired a HUGE new freezer. So NOW we’re expanding our

Read More »

FREEZE!!

As you know, metabolomics has the potential to be an effective tool for early disease diagnosis as well as for researching and monitoring new treatments

Read More »

Clinical-Microbiomics, CosmosID, DNASense, and MS-Omics have merged to form Cmbio. Please visit our new site cmbio.io

X